eXciteOSA®: A Revolutionary New Daytime Treatment for Mild Obstructive Sleep Apnea and Snoring

Advanced Sleep Apnea Treatments

Sleep apnea is a dangerous condition as it can create complications in one’s health — some of which can be severe or even life-threatening. Since sleep apnea can create an increase in pressure in the blood vessels around the heart, even some of the heart chambers themselves, thus increasing your risk of high blood pressure (hypertension). It can also increase the risk of heart attack, stroke, and abnormal heartbeats/atrial fibrillation.

At Airway and Sleep Group, we look for ways to help alleviate sleep apnea to improve your quality of life and protect your health. One such therapy we recommend is Signifier Medical Technologies’ eXciteOSA®, the world’s first clinically-proven daytime therapy for mild obstructive sleep apnea and primary snoring. 

According to recent estimates, 55 million adults in the U.S. suffer from obstructive sleep apnea, with more than half being mild cases. For these individuals, their quality of life suffers, with analysis showing a 224% increased risk of developing hypertension, an 83% more likely diagnosis of diabetes, and a 59% potential for abnormal fasting glucose.

The eXciteOSA® technology has shown reductions in both objectively measured and bed partner reported snoring, along with significant improvements in disease severity and sleep quality. 79% of sleep apnea patients achieved beneficial results, and 90% experienced reduction in objective snoring time.

What Is eXciteOSA and How Does it Work?

eXciteOSA is a daytime therapy device for sleep disordered breathing, used to improve daytime sleepiness and sleep quality.

One of the leading causes of OSA is the lack of endurance by upper airway muscles during sleep. The tongue falls back and blocks the upper airway. The eXciteOSA device uses neuromuscular electrical stimulation (NMES) to exercise and train the upper airway muscles, working both the intrinsic and extrinsic tongue muscles to help prevent airway collapse while sleeping. It physiologically retrains the tongue and upper airway to maintain the tongue’s natural position during sleep.

See a video demonstration how eXciteOSA works.

The stimulation device is used for just 20 minutes a day while you’re awake. It involves a mouthpiece device that’s applied to the tongue once a day for six weeks, and a smartphone app to control the stimulation intensity and provide guidance, information, and therapy reminders. It’s both comfortable and painless. Take the 2-minute assessment to see if you’re a candidate, then contact a healthcare professional at Airway and Sleep Group to schedule your sleep study and obtain your prescription.

eXciteOSA is the only daytime therapy for primary snoring and mild obstructive sleep apnea authorized by the FDA (Food & Drug Administration). It’s also the only commercially-available device to be used while awake. Others are meant to be used during sleep.

eXciteOSA: Daytime Treatment for Sleep Apnea With Airway & Sleep Group

At Airway & Sleep Group, we take your health seriously and are always looking for the latest and best innovations to improve your quality of life. The eXciteOSA device is the first of its kind, and we’re glad to make this technology available to you to help with mild obstructive sleep apnea or snoring issues.

If you live in Northern Virginia, contact Airway & Sleep Group. We serve residents throughout the Northern Virginia and the DC metropolitan area. To schedule your appointment to learn more and see if you’re an eXciteOSA® candidate, contact us at 571-244-7328, or visit airwayandsleepgroup.com